Cargando…
The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair (86)Y and (90)Y
In the context of radiopharmacy and molecular imaging, the concept of theranostics entails a therapy-accompanying diagnosis with the aim of a patient-specific treatment. Using the adequate diagnostic radiopharmaceutical, the disease and the state of the disease are verified for an individual patient...
Autores principales: | Rösch, Frank, Herzog, Hans, Qaim, Syed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490413/ https://www.ncbi.nlm.nih.gov/pubmed/28632200 http://dx.doi.org/10.3390/ph10020056 |
Ejemplares similares
-
Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review
por: Hussain, Mazhar, et al.
Publicado: (2023) -
Siderocalin fusion proteins enable a new (86)Y/(90)Y theranostic approach
por: Cosby, Alexia G., et al.
Publicado: (2023) -
Glypican-3 targeted delivery of (89)Zr and (90)Y as a theranostic radionuclide platform for hepatocellular carcinoma
por: Labadie, Kevin P., et al.
Publicado: (2021) -
Medical radionuclide production: science and technology
por: Qaim, Syed M
Publicado: (2020) -
Quantitative imaging of (124)I and (86)Y with PET
por: Lubberink, Mark, et al.
Publicado: (2011)